Boehringer Ingelheim, Lupin to market two anti-diabetic drugs

Pharma/BioPharma |  News | 0 Comment | 12 Jul, 2018

Boehringer Ingelheim and Lupin Limited (Lupin) announced the expansion of their partnership with plans to market two new oral anti-diabetics Gibtulio Met® (Empagliflozin + Metformin) an...Read more

Dr. Reddy’s announces launch of Plaquenil generic

Pharma/BioPharma |  News | 0 Comment | 11 Jul, 2018

Dr. Reddy’s Laboratories Ltd. has announced the launch of Hydroxychloroquine Sulfate Tablets USP, 200 mg, a therapeutic equivalent generic version of Plaquenil (hydroxychloroquine sul...Read more

DNP+ challenges patents on Gilead’s hepatitis C drugs

Pharma/BioPharma |  News | 0 Comment | 10 Jul, 2018

Delhi Network of Positive People (DNP+) has filed two patent oppositions before the Indian patent office, challenging additional patent claims by US pharmaceutical corporation-Gilead Scienc...Read more

China ready to slash Indian medicine tariffs

Pharma/BioPharma |  News | 0 Comment | 10 Jul, 2018

China and India have entered in an agreement to reduce tariffs and increase imports of Indian medicines, particularly anti-cancer drugs, part of moves to broaden its trade relations amid it...Read more

Lupin collaborates with European Association of Urology

Pharma/BioPharma |  News | 0 Comment | 02 Jul, 2018

Mumbai based pharma major Lupin and the European Association of Urology (EAU) have recently announced a collaboration to further the cause of Urology in India. With this collaboration, Lupi...Read more

Boiron launches pre-medicated homeopathic medicines in India

Pharma/BioPharma |  News | 0 Comment | 29 Jun, 2018

Boiron India, subsidiary of Boiron France, worldwide leader in homeopathy has launched pre-medicated standardised homeopathic medicines for the first time in India. The initiative will boos...Read more

Lupin, Mylan to commercialize Enbrel Biosimilar

Pharma/BioPharma |  News | 0 Comment | 28 Jun, 2018

Pharma major Lupin Limited and global pharmaceutical company Mylan have announced that the two companies will partner to commercialize a biosimilar to Enbrel (etanercept). Through the partn...Read more

AstraZeneca, Merck hope for expansion of Lynparza use

Pharma/BioPharma |  News | 0 Comment | 27 Jun, 2018

AstraZeneca's oncology business received a boost recently as results of a clinical trial showed its drug Lynparza helped women with ovarian cancer live longer without their disease worsenin...Read more

IIT-D, DSM Sinochem host workshop on effective manufacturing processes

Pharma/BioPharma |  News | 0 Comment | 26 Jun, 2018

DSM Sinochem Pharmaceuticals (DSP), a global leader in sustainable production of antibiotics, in collaboration with the Indian Institute of Technology (IIT), New Delhi hosted a Sustainabili...Read more

Lupin, Nichi-Iko unite to market biosimilar Etanercept in Japan

Pharma/BioPharma |  News | 0 Comment | 18 Jun, 2018

Pharma major Lupin and Nichi-Iko announced that the two companies have entered into an agreement for the distribution, promotion and sale of Lupin’s recently-filed biosimilar Etanerce...Read more

CPhI & P-MEC India 2018 shifts to Indian capital

Pharma/BioPharma |  News | 0 Comment | 12 Jun, 2018

CPhI & P-MEC India (December 10-14, 2018) organised by UBM announces that the 12th edition of Asia’s largest Pharma exhibition is moving to the India Expo Mart, New Delhi.  ...Read more

Cipla, Unitaid join hands to reduce HIV drug price

Pharma/BioPharma |  News | 0 Comment | 11 Jun, 2018

Cipla and Unitaid have inked a pact to lower the price of the first combination therapy (containing co-trimoxazole, isoniazid and vitamin B6) that prevents opportunistic infections in peopl...Read more

Cipla, Eli Lilly sign distribution agreement for diabetes drug

Pharma/BioPharma |  News | 0 Comment | 08 Jun, 2018

Cipla has entered into a partnership with Eli Lilly and Co (India) Pvt. Ltd., a 100 per cent subsidiary of Eli Lilly and Company, a global multinational pharmaceutical leader, for the marke...Read more

Pharma experts address quality as a critical issue

Pharma/BioPharma |  News | 0 Comment | 06 Jun, 2018

(L-R) Dr. Ajit Dangi (President & CEO, Danssen Consulting), Deepshika Jakate (Regional Quality Head-South Asia, GSK Pharmaceuticals Ltd), Ashwani Sood (Sr. Director- Industrial Affairs,...Read more

Granules Pharma launches generic Methylergonovine tablets

Pharma/BioPharma |  News | 0 Comment | 31 May, 2018

Granules Pharmaceuticals, Inc., the wholly owned subsidiary of Granules India Ltd., has launched the generic version of Methylergonovine Maleate Tablets, USP, 0.2mg, the generic equivalent ...Read more

Pharma Packaging Market to face significant growth

Pharma/BioPharma |  News | 0 Comment | 22 May, 2018

Packaging is greatest industry sections in the world of value in several billion. Pharmaceutical packaging signifies a small percentage of this immense market. The worldwide healthcare mar...Read more

Suven Life procures patents from New Zealand and Norway

Pharma/BioPharma |  News | 0 Comment | 22 May, 2018

Suven Life Sciences has been granted a product patent by New Zealand and Norway each corresponding to a new chemical entity (NCE) for treatment of disorders associated with neurodegenerativ...Read more

Indian Intellectual Property and liabilities law creates obstacle to invest in pharma sector

Pharma/BioPharma |  News | 0 Comment | 11 May, 2018

India’s intellectual property regulations and liabilities laws pose a major barrier to foreign companies, specially from the US, that prevents them from increasing their footprint in ...Read more